Efficacy of Sacubitril valsartan for chronic heart failure: A prospective observation study

Efficacy of Sacubitril valsartan for chronic heart failure: A prospective observation study - Efficacy of Sacubitril valsartan for chronic heart failure: A prospective observation study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041650

Enrollment

150

Registered

2020-09-02

Start date

2020-08-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure during ACE-i or ARB treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic heart failure using ACE-i or ARB

Exclusion criteria

Exclusion criteria: Patients who were deemed not appropriate to participate in this study by doctor

Design outcomes

Primary

Measure	Time frame
NT-Pro BNP	—

Secondary

Measure	Time frame
1) BNP, ANP 2) BUN, Cr, eGFR 3) cystatin C, urinary albumin, RAAS 4) UCG 5) ABI, FMD 6) Cardiovascular events 7) CPX, 6-min walk test 8) Holter ECG	—

Countries

Japan

Contacts

Public ContactMitsue Akiyama

Sekino Laboratory Department of Research

skn-np@sekino-hospital.com03-3986-5501

Outcome results